Browsing Category
Healthcare Industry News
2467 posts
Bridgepoint and Triton walk away from Spire Healthcare (LSE: SPI) as board keeps formal sale process alive with remaining bidders
Bridgepoint and Triton have walked away from Spire Healthcare's sale process. Find out what it means for SPI shareholders and what happens next. Read more.
Verana Health and Guardant Health link genomics and real-world data to accelerate precision oncology drug
Verana Health and Guardant Health (GH) combine EHR and genomic data to accelerate oncology drug development. Read the full strategic analysis.
Abbott (ABT) closes $21bn Exact Sciences deal, making it the leader in U.S. cancer screening diagnostics
Abbott (ABT) closes its $21bn Exact Sciences acquisition, creating a $12bn+ diagnostics leader in cancer screening and precision oncology. Read the full analysis.
Resonetics closes Resolution Medical deal, targeting full-stack dominance in neuromodulation and structural heart
Resonetics completes acquisition of Resolution Medical, adding biosimulation and finished device assembly to its neuromodulation and structural heart platform. Read the full analysis.
Artemis expansion signals rising pressure on adolescent mental health infrastructure in the US
Artemis Adolescent Healing Center expands teen treatment capacity in Arizona. Find out what this reveals about rising youth mental health demand.
Curi Bio and Battelle partner to scale human-relevant neuromuscular testing platforms as FDA shifts toward animal-free drug development
Curi Bio and Battelle announce strategic partnership to commercialize neuromuscular junction testing technology, positioning for regulatory shift toward human-relevant drug development methods.
Memphasys (ASX: MEM) holds MENA ground amid regional conflict, secures UAE and Iraq orders while Egypt and Turkey entry advances
Memphasys (ASX: MEM) secures UAE and Iraq Felix orders, confirms Egypt reseller deal and Turkey regulatory progress. Read the full MENA commercial strategy update.
Clinical trial site selection reimagined: PSI CRO deploys Arango-powered SYNETIC to eliminate $30,000 site failures
PSI CRO reduced clinical trial site selection from 6 weeks to minutes using SYNETIC on the Arango AI platform. Find out what this means for CRO competition. Read more.
ASX healthcare sector falls harder than the broader market as rate shock and Middle East war pressure high-multiple stocks
ASX healthcare stocks fell 2.47% on 19 March, lagging every other defensive sector. Here's what's driving CSL, Pro Medicus and Cochlear lower. Read more.
Lifeward (Nasdaq: LFWD) bets on oral insulin platform to escape medical device treadmill
Lifeward (LFWD) posts full-year 2025 revenue of $22M, down 14%, as shareholders approve the Oramed POD platform deal. Here is what it means for LFWD investors. Read more.